[HTML][HTML] SPIONs conjugate supported anticancer drug doxorubicin's delivery: current status, challenges, and prospects

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - Nanomaterials, 2022 - mdpi.com
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects

N Akhtar, HA Mohammed, M Yusuf… - Nanomaterials …, 2022 - pubmed.ncbi.nlm.nih.gov
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

[PDF][PDF] SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects. Nanomaterials 2022, 12, 3686

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - 2022 - pdfs.semanticscholar.org
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

[PDF][PDF] SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects. Nanomaterials 2022, 12, 3686

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - 2022 - researchgate.net
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects.

N Akhtar, HA Mohammed, M Yusuf… - Nanomaterials …, 2022 - search.ebscohost.com
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

[HTML][HTML] SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - …, 2022 - ncbi.nlm.nih.gov
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

[PDF][PDF] SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects. Nanomaterials 2022, 12, 3686

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - 2022 - academia.edu
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects

N Akhtar, HA Mohammed, M Yusuf… - …, 2022 - search.proquest.com
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects.

N Akhtar, HA Mohammed, M Yusuf… - Nanomaterials (Basel …, 2022 - europepmc.org
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …

[引用][C] SPIONs Conjugate Supported Anticancer Drug Doxorubicin's Delivery: Current Status, Challenges, and Prospects. Nanomaterials 2022, 12, 3686

N Akhtar, HA Mohammed, M Yusuf, A Al-Subaiyel… - 2022 - europepmc.org
Considerable efforts have been directed towards development of nano-structured carriers to
overcome the limitations of anticancer drug, doxorubicin's, delivery to various cancer sites …